SRPT — Sarepta Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapSucker Stock

Annual balance sheet for Sarepta Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,939	2,116	1,989	1,676	1,355
Net Total Accounts Receivable
Net Total Receivables	139	172	260	440	650
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,485	2,604	2,558	2,579	3,073
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	282	237	245	357	489
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,985	3,148	3,128	3,265	3,963
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	416	453	620	654	732
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2,223	2,220	2,743	2,405	2,435
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	762	928	385	859	1,528
Total Liabilities & Shareholders' Equity	2,985	3,148	3,128	3,265	3,963
Total Common Shares Outstanding